http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010198335-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bfd2c2f2bb0026db4d870cdf700616df |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-108 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T29-49885 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-86 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B23P25-00 |
filingDate | 2010-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_035221e2e4b1a0e1f4806508090f542b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32ef76cb2b862ad196fd4c4208da804c |
publicationDate | 2010-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2010198335-A1 |
titleOfInvention | Stent Coating For Eluting Medication |
abstract | A vascular stent comprising a drug-eluting outer layer of a porous sputtered columnar metal having each column capped with a biocompatible carbon-containing material is described. This is done by placing the stent over a close-fitting mandrel and rotating the assembly in a sputter flux. The result is a coating that is evenly distributed over the outward-facing side of the stent's wire mesh while preventing the sputtered columnar coating from reaching the inward facing side where a smooth hemocompatible surface is required. The stent is then removed from the mandrel, exposing all surfaces, and finally coated with a layer of carbon such as amorphous carbon or diamond-like carbon. The carbonaceous coating enhances biocompatibility without preventing elutriation of a therapeutic drug provided in the porosity formed between the columnar structures. The result is a stent that is adapted to both the hemodynamic and the immune response requirements of its vascular environment. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013004650-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8663317-B2 |
priorityDate | 2005-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.